Because of the latter reason, unbranded colchicine was pulled from Medicare part D formularies this year, and was replaced by Colcrys.
Whatever the outcome of the court battles, the situation isn’t permanent.
URL’s marketing exclusivity for Colcrys’s gout indications expires July 30, 2012. The familial Mediterranean fever indication expires July 29, 2016, according to the FDA’s Web site.
Information about URL’s Colcrys patient assistance program and copayment coupons are available by visiting Colcrys.com or by calling 888-811-8423. Copayment coupons can be downloaded at the Web site.
Dr. Fudman said that he had no relevant disclosures. Dr. Morris disclosed that he is on the speakers’ bureau for Takeda, Eli Lilly, and Forest Pharmaceuticals. Dr. Mandell disclosed that he is an advisor to Takeda and URL Pharma, and was a clinical investigator for Savient Pharmaceuticals.